Merit Medical Systems (MMSI) Financials

$89.60

$1.03 (1.16%)

As on 04-Sep-2026 16:05EDT

Market cap

$5,350 Mln

Revenue (TTM)

$1,579 Mln

P/E Ratio

36.9

P/B Ratio

3.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	1,579.17	1,514.73	1,356.51	1,257.37	1,150.98	1,074.75
Cost of Revenue	797.24	777.79	713.18	673.49	631.88	589.42
Gross Profit	781.93	736.94	643.33	583.87	519.10	485.33
Operating Expenses	580.58	552.57	487.64	458.73	431.54	424.42
Operating Profit (EBIT)	201.35	184.38	155.69	123.94	87.56	60.92
Other Income	--	--	--	--	1.41	-1.74
Profit before Tax	194.46	170.94	149.99	112.09	82.63	53.92
Provision for Tax	48.90	42.45	29.64	17.68	8.11	5.46
Profit after Tax (Net Income)	145.56	128.49	120.36	94.41	74.52	48.45
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	74.52	48.45

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	1,679.80	1,584.30	1,379.36	1,202.00	1,144.40	1,039.80
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	918.88	861.85	822.84	919.68	298.92	372.22
Current Liabilities	264.93	239.76	216.40	203.56	220.65	236.28
Total Liabilities	3,128.55	2,685.92	2,418.60	2,325.24	1,663.97	1,648.29

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	1,751.38	1,645.77	1,494.83	1,216.77	1,134.88	1,166.08
Current Assets	1,112.24	1,040.15	923.77	1,108.47	529.08	482.21
Total Assets	3,128.55	2,685.92	2,418.60	2,325.24	1,663.97	1,648.29
Total Debt*	820.12	898.23	794.67	891.36	279.76	325.70
Net Current Assets	847.31	800.39	707.37	904.91	308.44	245.93

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	297.37	220.80	145.15	114.29	147.23
Cash Flow from Investing Activities	--	-247.39	-368.65	-175.35	-57.40	-37.16
Cash from Financing Activities	--	16.00	-60.01	559.27	-60.26	-98.44
Net Cash Inflow / Outflow	--	--	--	--	-3.37	11.64

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	2.43	2.14	1.99	1.62	1.29	0.84
Cash EPS ($)	--	4.38	3.88	3.30	2.88	2.50
Adjusted Book Value ($)	--	26.39	22.76	20.59	19.74	18.04
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	4.95	3.64	2.49	1.97	2.56
Free Cash Flow per Share ($)	--	3.54	3.02	1.86	1.19	2.07

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	5.52	5.64	5.37	5.34	3.50
ROE (%)	8.92	8.67	9.33	8.05	6.82	4.85
ROA (%)	4.90	5.03	5.07	4.73	4.50	2.93
EBIT Margin (%)	14.33	13.03	11.74	10.15	7.73	5.51
Net Margin (%)	9.22	8.48	8.87	7.51	6.47	4.52
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	10.33	0.12	0.08	0.09	0.07	0.12
EBIT Growth (%)	25.52	23.97	24.79	43.42	50.34	1,928.17
Net Profit Growth (%)	22.20	6.76	27.48	26.70	53.79	592.27
EPS Growth (%)	23.26	0.08	0.23	0.26	0.53	5.85
Book Value Growth (%)	14.02	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	36.87	41.18	48.71	46.97	54.93	74.09
Price / Book Value	3.20	3.34	4.25	3.69	3.58	3.45
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	15.89	17.29	22.92	20.70	23.82	24.83
Close Price ($)	69.34	88.14	96.72	75.96	70.62	62.30
High Price ($)	96.74	111.45	108.08	85.62	76.14	73.85
Low Price ($)	59.74	78.12	70.70	62.58	50.46	52.43
Market Cap ($ Cr)	5,350.05	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.44	0.57	0.58	0.74	0.24	0.31
Short term debt to equity ratio	0.01	0.01	0.01	0.01	0.03	0.03
Current Ratio	4.20	4.34	4.27	5.45	2.40	2.04
Quick Ratio	2.79	2.95	2.85	3.95	1.19	1.10
Interest Coverage	7.12	7.46	5.10	8.23	14.04	11.25

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	15.89	14.76	15.42	15.05	15.50	16.08
Asset Turnover	0.53	0.59	0.57	0.63	0.69	0.65
Receivable days	--	52.18	53.64	53.41	55.74	56.21
Inventory Days	--	150.22	156.19	154.52	141.02	130.11
Payable days	--	30.30	34.43	36.46	35.88	32.68
Cash Conversion Cycle	--	172.09	175.40	171.47	160.88	153.65

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.